Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2485 ARTÍCULOS , VIENDO DEL 886 AL 900

HSV-1 as a Potential Driver of Alzheimer's Disease

Li DY, Choi ES, Bao X.

Pathogens. 2025 Oct 8;14(10):1022. doi: 10.3390/pathogens14101022.

Bridging the gap in the management of Alzheimer's disease using fecal microbiota transplantation

Bashir B, Gulati M, Vishwas S, Hussain MS, Gupta G, Kumar P, Negi P, Mittal N, Dua K, Singh SK.

Mol Cell Neurosci. 2025 Dec;135:104052. doi: 10.1016/j.mcn.2025.104052. Epub 2025 Nov 1.

Amyloid-β Seeds in Alzheimer's Disease: Research Challenges and Implications

Beschorner N, Xu Y, Jucker M, Ruiz-Riquelme A.

J Neurochem. 2025 Nov;169(11):e70267. doi: 10.1111/jnc.70267.

Monoclonal Antibody Therapies in Alzheimer's Disease: A Guide for Emergency Physicians

Wrigley S, Huynh ALH, Amadoru S, Zeimer H, Tan I, Woodward M, Braitberg G, Yates PA.

Emerg Med Australas. 2025 Dec;37(6):e70167. doi: 10.1111/1742-6723.70167.

The Role of T Cells in Alzheimer's Disease

Lin Y, Zhao H, Meng D, Wang M.

Crit Rev Immunol. 2025;45(6):53-67. doi: 10.1615/CritRevImmunol.2025061107.

The Multi-Dimensional Action Map of Resveratrol Against Alzheimer's Disease: Mechanism Integration and Treatment Strategy Optimization

Liu Y, Dong Y, Cao Z, Ji Y, Cheng X, Zheng X.

Nutrients. 2025 Oct 31;17(21):3451. doi: 10.3390/nu17213451.

Therapeutic Potentials of the Seaweed-Derived Compounds for Alzheimer's Disease

Ward K, Cole MH, Griffiths LR, Sutherland HG, Winberg P, Meyer BJ, Fernandez F.

Molecules. 2025 Nov 19;30(22):4456. doi: 10.3390/molecules30224456.

Unveiling the Neuroprotective Effect of Paraoxonase 1 in Neurodegenerative Diseases Focusing on Alzheimer's Disease

Ismail A, Al-Kuraishy HM, Al-Gareeb AI, Alexiou A, Papadakis M, Faheem SA, Batiha GE.

Mol Neurobiol. 2025 Dec 3;63(1):244. doi: 10.1007/s12035-025-05493-1.

Targeting Microglial Activation to Modulate Neuroinflammation in Alzheimer's Disease

Patil V, Sharma A, Parekh B, Farah H, Jyothi SR, Mishra S, Nanda A, Al-Hasnaawei S, Mishra MK.

Neuromolecular Med. 2025 Dec 4;27(1):76. doi: 10.1007/s12017-025-08898-2.

Unraveling the oral microbiome's role in Alzheimer's disease: From pathophysiology to therapeutic potential

Rozenblum G, Ait-Aissa K, Zahran G, Alipour M, Sahyoun AM, Munkhsaikhan U, Kassan A, Ishrat T, Wang Q, Abidi AH, Kassan M.

Alzheimers Dement. 2025 Dec;21(12):e71011. doi: 10.1002/alz.71011.

Deep learning for Alzheimer's disease: advances in classification, segmentation, subtyping, and explainability

Shaikh MR, Jeyabose A, Arjunan RV.

Biomed Eng Online. 2025 Dec 29;24(1):150. doi: 10.1186/s12938-025-01482-6.

The Determinant of Tau Spreading in Alzheimer's Disease: Dependent on Senile Plaque, Neural Circuits, or Spatial Proximity?

Riku Y, Brion JP, Ando K, Uchihara T, Iwasaki Y.

Int J Mol Sci. 2025 Dec 16;26(24):12088. doi: 10.3390/ijms262412088.

Molecular links between inflammatory bowel disease and Alzheimer's disease through immune signaling and inflammatory pathways

Durairajan SSK, Singh AK, Sulaiman SM, Patnaik S, Krishnamoorthi S, Iyaswamy A, Vellingiri B, Yang CB, Williams LL.

World J Gastroenterol. 2025 Dec 28;31(48):111301. doi: 10.3748/wjg.v31.i48.111301.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias